IMR Press / JOMH / Special Issues / 1446651469371457536

The Relationship of Lifestyle/Medications to Male Infertility

Submission deadline: 20 May 2022
Special Issue Editors
Matthew Wosnitzer, MD
FACS, Yale New Haven Health System/Northeast Medical Group Urology, Fairfield CT, USA
Interests: Male infertility
Special Issue Information

Dear Colleagues,

Some studies indicate that semen quality in men has declined in certain parts of the world in recent decades; however, the reasons for the decline in semen parameters have not been completely identified. Factors may include poor diet (leading to obesity and/or diabetes, cardiovascular disease) and environment (smoking, alcohol, marijuana, and other toxic chemicals including pollutants and pesticides), as well as medications (including narcotics, antibiotics, anti-hypertensives, exogenous testosterone), in addition to other causes such as genetics. Some mechanisms of the above may include alteration of testosterone/hormonal balance, while other effects occur from direct alterations of sperm production. Comprehensive counseling for couples with male factor infertility who try to conceive requires recommendations on lifestyle/diet and the possible negative effects of medication.

Aim: To provide practitioners with a concise summary of the latest studies/evidence to assist with counseling patients on the influence of lifestyle and medications on male factor infertility. Many commonly encountered issues related to diet and prescribed medications exhibit negative effects on male reproduction and spermatogenesis. Given the potentially significant impact, lifestyle and medications should be considered in the counseling of couples considering fertility and those with infertility. 

Dr. Matthew Wosnitzer

Guest Editor

Keywords
Male Infertility and Effect of: Obesity
Diabetes
Cardiovascular disease
Smoking/Alcohol/Marijuana/Other drugs
Pesticides/pollution
Medications – urologic; exogenous testosterone; 5-alpha reductase inhibitors; anti-hypertensive medications; anti-infection medications; anticancer medications; narcotics
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 1500 USD. Submitted manuscripts should be well formatted in good English.

Back to top